Switching from full-list blasts to behaviorally segmented campaigns lifts every performance metric simultaneously for a newly licensed New York dispensary.
A newly licensed New York cannabis dispensary was sending identical email and SMS campaigns to their entire list, treating every customer the same regardless of purchase history. Open rates were modest, revenue per send was leaving money on the table, and there was no visibility into whether messaging was resonating with different buyer types. The objective: implement behavioral segmentation, run both approaches simultaneously, and measure the 30-day performance gap.
We build behaviorally segmented email and SMS programs for dispensaries across NY, NJ, and PA.
A concentrates-only campaign sent to 1,474 buyers generates more revenue than a cross-category broadcast to 3,170. Smaller list. Sharper targeting. Better result.
One Manhattan dispensary grew strict-attributed monthly revenue from $2,031 to $9,629 in 90 days by putting its full list to work, switching on loyalty automations, and sending to a more responsive audience.
A 2-store Queens dispensary group generates over $127K in strictly-attributed monthly revenue through email marketing alone, no SMS required.
One dispensary location generates over $104K in monthly attributed marketing revenue with 1,704 orders tracked to campaigns in a single month.
A high-volume NYC dispensary generates $129K in SMS revenue under the most conservative attribution model over a 3-month window, proving SMS as a standalone revenue channel.
Automated flows outperform manual blasts at a 2-location NYC dispensary, generating 62% of strictly-attributed revenue with zero ongoing staff labor.
A 90-day full-funnel programmatic blend, Display, CTV, Pre-Roll and DOOH, drives 229 net-new shoppers into a Manhattan dispensary at a $54.18 CPA, then hands them to the loyalty program where members generate 96% of store revenue.
A single targeted post-purchase SMS campaign generates $17,324 in strictly attributed revenue from a sub-$10 send investment for a Brooklyn cannabis dispensary.